Dosar de subiect

Altele

Europe Urged to Increase Clinical Trials

Primul articol: 15 apr. 2026, 06:00 | Ultima actualizare: 15 apr. 2026, 06:00 | 1 sursa | 1 articol
#clinicaltrials#healthcare#europe#research

Mai multe surse. Mai putina manipulare.

Analiza editoriala

Bazat pe 1 sursa, 1 articol

Europe is being urged to increase its number of clinical trials to improve healthcare outcomes and maintain its position in global research and development. The current state of clinical trials in Europe is lagging behind other regions, potentially hindering medical advancements and economic growth. Increased investment and streamlined regulations are seen as key to boosting clinical trial activity across the continent. The European Federation of Pharmaceutical Industries and Associations (EFPIA) is involved.

Articole despre acest subiect

Politico EU English Carlos Gallardo, chairman and CEO, Almirall; second vice president, European Federation of Pharmaceutical Industries and Associations (EFPIA) 15 apr. 2026, 06:00 (acum 2 ore)

Why Europe should strive to increase its clinical trials

Clinical trials are essential in bringing new, improved treatment options to patients. They support our hospitals, bringing new infrastructure and skills, and anchor research in Europe.

Citeste pe Politico EU →